We are live on ! Find out more
OCAT

OCATA THERAPEUTICS, INC. COMMON STOCK
OCAT

Delisted

OCAT was delisted on the 9th of February, 2016.

63 hedge funds and large institutions have $26.4M invested in OCATA THERAPEUTICS, INC. COMMON STOCK in 2015 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 25 increasing their positions, 11 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

127% more repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 11

50% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 6

5% more funds holding

Funds holding: 6063 (+3)

15% less capital invested

Capital invested by funds: $31M → $26.4M (-$4.59M)

96% less call options, than puts

Call options by funds: $10K | Put options by funds: $274K

Holders
63
Holders Change
+3
Holders Change %
+5%
% of All Funds
1.75%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
9
Increased
25
Reduced
11
Closed
6
Calls
$10K
Puts
$274K
Net Calls
-$264K
Net Calls Change
-$17K

OCAT Hedge Fund Activity: Q3 2015 in Review

63 of the 3,590 institutional investors tracked by Wall St. Rank reported a position in OCATA THERAPEUTICS, INC. COMMON STOCK (OCAT) for Q3 2015, worth a combined $26.4M — down 15% from $31M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new OCAT positions and 6 closed out — a net gain of 3 holders — while 25 added to existing stakes and 11 trimmed.

The largest buyer was BlackRock Institutional Trust, adding an estimated $1.53M. The largest seller was Sabby Management, exiting entirely with an estimated $1.86M sold.

  • 63 institutional investors held OCATA THERAPEUTICS, INC. COMMON STOCK (OCAT) as of Q3 2015, up from 60 in Q2 2015.
  • Funds reported $26.4M of OCATA THERAPEUTICS, INC. COMMON STOCK stock for Q3 2015, down 15% quarter-over-quarter.
  • 9 funds opened new OCATA THERAPEUTICS, INC. COMMON STOCK positions in Q3 2015 and 6 closed out, a net change of +3 holders.
  • The largest OCATA THERAPEUTICS, INC. COMMON STOCK buyer in Q3 2015 was BlackRock Institutional Trust, an estimated $1.53M added.
  • The largest OCATA THERAPEUTICS, INC. COMMON STOCK seller in Q3 2015 was Sabby Management, an estimated $1.86M sold.

Based on aggregated 13F filings for Q3 2015.